Promoter methylation of TFPI2 is detected in most of tumors (over 90% tested cancer patients samples) with OSCC and other cancer types [21] as well which explained TFPI2 methylation can be useful for early detection biomarker rather than prognostic biomarkers. This evidence concerns the gene TFPI2 and cancer.